tadalafil has been researched along with Ventricular Fibrillation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beasley, CM; Crumb, WJ; Dustan Sarazan, R; Emmick, JT; Ferguson, KM; Sausen, PJ; Strnat, CA | 1 |
1 other study(ies) available for tadalafil and Ventricular Fibrillation
Article | Year |
---|---|
Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5--sildenafil, tadalafil, and vardenafil.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cation Transport Proteins; Cell Line; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Heart Rate; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Potassium Channels, Voltage-Gated; Purines; Sildenafil Citrate; Sulfones; Tachycardia, Ventricular; Tadalafil; Triazines; Vardenafil Dihydrochloride; Ventricular Fibrillation | 2004 |